Is CVE-2021-31868 being actively exploited?

CVE-2021-31868 is not currently listed in the CISA Known Exploited Vulnerabilities (KEV) catalog.

What is the CVSS score for CVE-2021-31868?

CVE-2021-31868 has a CVSS 3.1 base score of 4.3 (MEDIUM).

CVE-2021-31868

MEDIUM · CVSS 4.3EPSS 0.5%EU EUVD

Rapid7 Nexpose version 6.6.95 and earlier allows authenticated users of the Security Console to view and edit any ticket in the legacy ticketing feature, regardless of the assignment of the ticket. This issue was resolved in version 6.6.96, released on August 4, 2021.

Key facts

CVSS score: 4.3 (v3.1)
Severity: MEDIUM
CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Weakness (CWE): CWE-306
EPSS score: 0.5% (40th percentile)
In CISA KEV: No
In EU EUVD: Yes (EUVD-2021-18743)
Published: August 19, 2021
NVD last modified: June 17, 2026
Status: Modified

EU Vulnerability Database (EUVD)

This vulnerability is also tracked by ENISA as EUVD-2021-18743 in the EU Vulnerability Database. Last updated in EUVD on September 17, 2024.

View on the EU Vulnerability Database

Affected products

rapid7 / nexpose

Certified products that may be affected

1 FIPS 140 or Common Criteria certified product, from automated matching by sec-certs.org.

Rapid7™ Nexpose™ Vulnerability Management and Penetration Testing System V5.1 - Rapid7 LLC - Common Criteria 383-4-148 - archived

References

https://docs.rapid7.com/release-notes/nexpose/20210804/(Release Notes, Vendor Advisory)

Last updated September 17, 2026 · Source: NVD, CISA KEV, FIRST.org EPSS

Query CVEs from your AI assistant

The CVE/NVD Explorer brain answers CVE questions directly inside Claude, ChatGPT, or any MCP assistant — always up to date, no setup. Add it once and stop pasting advisories into chat.

Add the CVE brain